Argus Gives Allergan (AGN) Lower Rating. “Buy” Rating Lost; Howard Hughes Medical Institute Has Boosted Credit Accep Mich (CACC) Position By $7.22 Million

December 7, 2017 - By Darrin Black

Howard Hughes Medical Institute increased Credit Accep Corp Mich (CACC) stake by 55.24% reported in 2017Q2 SEC filing. Howard Hughes Medical Institute acquired 28,082 shares as Credit Accep Corp Mich (CACC)’s stock rose 15.18%. The Howard Hughes Medical Institute holds 78,918 shares with $20.29M value, up from 50,836 last quarter. Credit Accep Corp Mich now has $5.98 billion valuation. The stock decreased 0.09% or $0.29 during the last trading session, reaching $308.78. About 192,131 shares traded. Credit Acceptance Corporation (NASDAQ:CACC) has risen 27.46% since December 7, 2016 and is uptrending. It has outperformed by 10.76% the S&P500.

Among 25 analysts covering Allergan Inc. (NYSE:AGN), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Allergan Inc. has $400 highest and $193.0 lowest target. $269.86’s average target is 60.63% above currents $168 stock price. Allergan Inc. had 96 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Thursday, April 7 by Susquehanna. Deutsche Bank maintained Allergan plc (NYSE:AGN) on Monday, July 17 with “Buy” rating. Credit Suisse maintained Allergan plc (NYSE:AGN) on Thursday, July 20 with “Buy” rating. Piper Jaffray maintained it with “Hold” rating and $22700 target in Thursday, August 3 report. The firm has “Buy” rating by RBC Capital Markets given on Thursday, August 3. The firm earned “Buy” rating on Friday, October 9 by Mizuho. The company was maintained on Thursday, October 19 by Citigroup. As per Friday, October 6, the company rating was maintained by Piper Jaffray. The firm has “Buy” rating by Mizuho given on Friday, June 9. The stock of Allergan plc (NYSE:AGN) earned “Equal-Weight” rating by Morgan Stanley on Thursday, November 2.

Investors sentiment decreased to 1.3 in 2017 Q2. Its down 0.01, from 1.31 in 2017Q1. It turned negative, as 20 investors sold CACC shares while 43 reduced holdings. 29 funds opened positions while 53 raised stakes. 13.72 million shares or 4.67% more from 13.11 million shares in 2017Q1 were reported. Gabelli Funds Ltd has 1,250 shares for 0% of their portfolio. Brandywine Global Invest Mngmt Limited Liability has 81,890 shares. Abrams Bison Invs Ltd Liability invested in 52.52% or 1.17 million shares. Deutsche Commercial Bank Ag invested 0% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC). Blair William And Il, Illinois-based fund reported 11,567 shares. Bancshares Of America De invested 0% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC). 1,168 were accumulated by M&T National Bank. First Financial Bank Of Omaha reported 21,648 shares. Ingalls Snyder Ltd Liability Com has invested 1.27% in Credit Acceptance Corporation (NASDAQ:CACC). Alliancebernstein Limited Partnership accumulated 6,519 shares. Wells Fargo & Com Mn holds 3,674 shares or 0% of its portfolio. Geode Cap Mgmt Ltd invested in 102,957 shares. 2,045 are owned by Utah Retirement System. Howard Hughes Institute holds 3.7% or 78,918 shares in its portfolio. 18 are owned by Point72 Asia (Hong Kong).

Among 11 analysts covering Credit Acceptance Corp (NASDAQ:CACC), 0 have Buy rating, 6 Sell and 5 Hold. Therefore 0 are positive. Credit Acceptance Corp had 23 analyst reports since July 31, 2015 according to SRatingsIntel. On Wednesday, March 16 the stock rating was downgraded by JMP Securities to “Market Underperform”. The stock of Credit Acceptance Corporation (NASDAQ:CACC) has “Hold” rating given on Tuesday, August 1 by Raymond James. Zacks downgraded the shares of CACC in report on Tuesday, August 4 to “Buy” rating. The stock has “Hold” rating by Jefferies on Thursday, September 7. The firm has “Hold” rating given on Tuesday, October 31 by Jefferies. JMP Securities upgraded the shares of CACC in report on Wednesday, August 26 to “Market Perform” rating. The company was maintained on Tuesday, October 31 by BMO Capital Markets. BMO Capital Markets maintained it with “Market Perform” rating and $238 target in Tuesday, August 1 report. The stock has “Neutral” rating by Susquehanna on Monday, January 23. The firm earned “Neutral” rating on Tuesday, November 10 by Compass Point.

Howard Hughes Medical Institute decreased Home Depot Inc (NYSE:HD) stake by 8,839 shares to 28,166 valued at $4.32 million in 2017Q2. It also reduced Hershey Co (NYSE:HSY) stake by 5,000 shares and now owns 45,000 shares. Aercap Holdings Nv (NYSE:AER) was reduced too.

Analysts await Allergan plc (NYSE:AGN) to report earnings on February, 14. They expect $4.74 EPS, up 21.54% or $0.84 from last year’s $3.9 per share. AGN’s profit will be $1.58B for 8.86 P/E if the $4.74 EPS becomes a reality. After $4.15 actual EPS reported by Allergan plc for the previous quarter, Wall Street now forecasts 14.22% EPS growth.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The company has market cap of $55.87 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions. It currently has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womenÂ’s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as AlzheimerÂ’s disease.

Investors sentiment decreased to 0.38 in Q2 2017. Its down 2.62, from 3 in 2017Q1. It turned negative, as 4 investors sold Allergan plc shares while 4 reduced holdings. 0 funds opened positions while 3 raised stakes. 57,100 shares or 18.39% less from 69,971 shares in 2017Q1 were reported. Eqis Cap Incorporated has 0.1% invested in Allergan plc (NYSE:AGN) for 7,291 shares. Mitchell Mcleod Pugh Williams stated it has 0.73% of its portfolio in Allergan plc (NYSE:AGN). Gemmer Asset Management Ltd Limited Liability Company invested in 0.01% or 135 shares. Frontier Investment Mngmt invested 0.71% in Allergan plc (NYSE:AGN). Grassi Investment Mgmt reported 0.36% in Allergan plc (NYSE:AGN). Connors Investor Services has invested 0.04% in Allergan plc (NYSE:AGN). Bartlett Ltd Liability Corporation holds 0% of its portfolio in Allergan plc (NYSE:AGN) for 21 shares. American Rech & Management owns 33 shares for 0% of their portfolio. Dowling Yahnke Ltd Liability Corp has invested 0.05% in Allergan plc (NYSE:AGN). Toth Advisory Corporation has invested 0.06% in Allergan plc (NYSE:AGN). Marshwinds Advisory, Georgia-based fund reported 892 shares. Cubic Asset Mngmt Llc stated it has 2,311 shares or 0.16% of all its holdings.

The stock increased 2.26% or $3.72 during the last trading session, reaching $168. About 3.66M shares traded. Allergan plc (NYSE:AGN) has declined 3.42% since December 7, 2016 and is downtrending. It has underperformed by 20.12% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.